Robert Davies analyst MORGAN STANLEY

Currently out of the existing stock ratings of Robert Davies, 6 are a HOLD (85.71%), 1 are a BUY (14.29%).

Robert Davies

Work Performance Price Targets & Ratings Chart

Analyst Robert Davies, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 33.33% that have a potential upside of 4.9% achieved within 23 days.

Robert Davies’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 20-Oct-2023.

Wall Street Analyst Robert Davies

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 1/31/2023. The price target of $16.28 was fulfilled within 1 day with a profit of $0.43 (2.71%) receiving and performance score of 27.13.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SNN Smith & Nephew SNATS

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25.6

$3.44 (15.52%)

$50.41

19 days ago
(06-Nov-2024)

0/12 (0%)

$4.75 (22.78%)

Hold

$23

$0.84 (3.79%)

$22

1 months 18 days ago
(07-Oct-2024)

5/12 (41.67%)

$2.41 (11.70%)

144

Hold

$34

1 years 1 days ago
(24-Nov-2023)

0/2 (0%)

$15.46 (83.39%)

$36.47

$14.31 (64.58%)

$50.57

1 years 16 days ago
(09-Nov-2023)

4/15 (26.67%)

$19.39 (113.52%)

137

Sell

$29.84

$7.68 (34.66%)

$33.99

1 years 22 days ago
(03-Nov-2023)

3/15 (20%)

$12.41 (71.20%)

116

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Robert Davies?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?